HomeNewsIngredients

Andera Partners Targets EUR 10 Billion AUM as It Accelerates Innovation and European Expansion

Andera Partners Targets EUR 10 Billion AUM as It Accelerates Innovation and European Expansion

Andera Partners is reinforcing its long-term growth strategy by combining sustained investment activity, active portfolio management and strong fundraising momentum, despite a challenging economic environment marked in 2025 by a global slowdown and a more than 20 percent decline in private equity investments in France.

In response to market headwinds, Andera has placed innovation at the core of its investment approach, focusing on sectors undergoing deep structural transformation. This strategy is particularly evident in healthcare, where the firm’s Andera Life Sciences platform currently supports 31 companies in clinical development, involved in 33 late-stage trials that have already led to the approval of six new products. These investments reflect the firm’s ambition to back high scientific and technological content capable of transforming healthcare delivery while generating sustainable returns for investors.

As technological progress accelerates, Andera is also integrating data, artificial intelligence and digital tools to enhance investment analysis, selection and portfolio monitoring. Recognising this pivotal shift, the firm has appointed Mickaël Clavier as chief digital and data officer, reinforcing its commitment to leveraging AI, predictive analytics and automation alongside its sector expertise and human-driven investment culture.

The firm continues to expand its European footprint. Andera Acto has strengthened its network of senior advisors across Germany, Belgium and Italy, with Spain to follow, supporting the international growth of its sponsorless mezzanine strategy. In Italy, Francesco Gonzaga was promoted to Partner in Milan in early 2025, while the Madrid office has been reinforced with new hires to support the Andera MidCap strategy.

Looking ahead, Andera Partners has set a five-year objective to reach EUR 10 billion in assets under management, building on its three core investment pillars: healthcare through Andera Life Sciences; SME and mid-sized business financing through Andera Expansion, Andera MidCap, Andera Acto and Andera Co-Invest; and energy transition infrastructure through Andera Infra.

Following the final close of Andera Acto V at EUR 1.1 billion, the firm is advancing fundraising for several vehicles in 2026, including Andera Expansion 4 and BioDiscovery 7, while Andera Smart Infra II, Andera MidCap 6 and Andera Co-Invest III are already experiencing strong investor demand.

With nearly EUR 5.1 billion currently under management and more than 130 employees across offices in Paris, Antwerp, Madrid, Milan and Munich, Andera Partners continues to position itself as a leading European private equity platform. In parallel, Andera Infra has released a white paper highlighting the strategic importance of infrastructure in driving the energy transition, underlining the firm’s commitment to supporting sustainable transformation across Europe.

More news about: ingredients | Published by Darshana | February - 23 - 2026

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members